LY-395153
LY-395153 is a chemical compound that has been studied for its potential effects on the central nervous system. It is primarily known as a selective agonist for the 5-HT2A receptor, a subtype of the serotonin receptor family. This compound has been of interest in pharmacological research due to its potential implications in the treatment of various neuropsychiatric disorders.
Chemical Structure and Properties[edit]
LY-395153 is a synthetic compound with a complex molecular structure. It is characterized by its affinity for the 5-HT2A receptor, which is a G protein-coupled receptor (GPCR) involved in various neurological processes. The chemical formula of LY-395153 is C_20H_25N_3O_2, and it has a molecular weight of 339.44 g/mol.
Pharmacodynamics[edit]
As a selective agonist of the 5-HT2A receptor, LY-395153 mimics the action of serotonin (5-HT) at this receptor site. The 5-HT2A receptor is widely distributed in the brain, particularly in areas such as the prefrontal cortex, hippocampus, and thalamus. Activation of this receptor is associated with various effects, including modulation of mood, perception, and cognition.
Pharmacokinetics[edit]
The pharmacokinetic profile of LY-395153 involves its absorption, distribution, metabolism, and excretion. While specific data on LY-395153 may be limited, compounds of this class typically undergo hepatic metabolism and are excreted via the renal route. The bioavailability and half-life of LY-395153 would be critical factors in determining its potential therapeutic use.
Potential Therapeutic Applications[edit]
Research into LY-395153 has explored its potential use in treating conditions such as depression, anxiety disorders, and schizophrenia. The modulation of the 5-HT2A receptor is a common target in the treatment of these disorders, as it plays a role in regulating mood and emotional responses.
Research and Development[edit]
Studies on LY-395153 have primarily been conducted in preclinical settings. Animal models have been used to assess its efficacy and safety profile. The compound's ability to cross the blood-brain barrier and its selectivity for the 5-HT2A receptor are key factors in its development as a potential therapeutic agent.
Safety and Side Effects[edit]
As with any pharmacological agent, the safety profile of LY-395153 is of paramount importance. Potential side effects may include alterations in mood, perception, and cognition, which are consistent with its action on the 5-HT2A receptor. Further studies are required to fully elucidate its safety and tolerability in humans.
Also see[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

